Oncolytics Biotech Inc (ONCY)
1.04
0.00 (0.00%)
USD |
NASDAQ |
Apr 19, 16:00
1.04
0.00 (0.00%)
After-Hours: 20:00
Oncolytics Biotech Cash from Operations (TTM)
Cash from Operations (TTM) Chart
Historical Cash from Operations (TTM) Data
| Date | Value |
|---|---|
| December 31, 2022 | -17.95M |
| September 30, 2022 | -18.45M |
| June 30, 2022 | -18.13M |
| March 31, 2022 | -18.43M |
| December 31, 2021 | -17.89M |
| September 30, 2021 | -16.99M |
| June 30, 2021 | -19.17M |
| March 31, 2021 | -17.91M |
| December 31, 2020 | -16.47M |
| September 30, 2020 | -17.68M |
| June 30, 2020 | -16.29M |
| March 31, 2020 | -15.40M |
| December 31, 2019 | -15.00M |
| September 30, 2019 | -13.02M |
| June 30, 2019 | -12.16M |
| March 31, 2019 | -8.095M |
| December 31, 2018 | -9.198M |
| September 30, 2018 | -7.939M |
| June 30, 2018 | -8.291M |
| March 31, 2018 | -12.16M |
| December 31, 2017 | -11.49M |
| September 30, 2017 | -12.08M |
| June 30, 2017 | -11.36M |
| March 31, 2017 | -10.20M |
| December 31, 2016 | -9.422M |
| Date | Value |
|---|---|
| September 30, 2016 | -10.23M |
| June 30, 2016 | -9.764M |
| March 31, 2016 | -11.76M |
| December 31, 2015 | -11.78M |
| September 30, 2015 | -10.99M |
| June 30, 2015 | -13.27M |
| March 31, 2015 | -14.45M |
| December 31, 2014 | -17.82M |
| September 30, 2014 | -19.48M |
| June 30, 2014 | -21.47M |
| March 31, 2014 | -20.98M |
| December 31, 2013 | -23.73M |
| September 30, 2013 | -25.91M |
| June 30, 2013 | -27.97M |
| March 31, 2013 | -34.13M |
| December 31, 2012 | -34.27M |
| September 30, 2012 | -34.76M |
| June 30, 2012 | -33.25M |
| March 31, 2012 | -27.37M |
| December 31, 2011 | -22.80M |
| September 30, 2011 | -19.32M |
| June 30, 2011 | -17.44M |
| March 31, 2011 | -16.50M |
| December 31, 2010 | -17.33M |
| September 30, 2010 | -16.66M |
Cash From Operations Definition
Cash flow from operations is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall operating activities of the company. A few examples of operating activities include change in receivables, change in inventories, and changes in current assets.
Cash from Operations (TTM) Range, Past 5 Years
-19.17M
Minimum
Jun 2021
-12.16M
Maximum
Jun 2019
-16.73M
Average
-17.68M
Median
Sep 2020
Cash from Operations (TTM) Benchmarks
| Acasti Pharma Inc | -13.57M |
| Aurinia Pharmaceuticals Inc | -33.46M |
| Edesa Biotech Inc | -6.252M |
| Lexaria Bioscience Corp | -5.209M |
| Xenon Pharmaceuticals Inc | -145.33M |